Metraipolis › archive › dc_a198dfb538a2

Investigating the Mechanisms of Combined Therapy for MCF-7 Breast Cancer Cells Using Arsenic Trioxide and Resveratrol through Network Pharmacology — Europe PMC PMID:41675270

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41675270
DOI
10.1007/s43657-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-07T12:47:49.642Z
SHA-256 of the archived text
058cb9b316d392aca8559a0bce39df3afedd81e9ab0a65e2b0be8107f323afc6
Stable URL of this page
https://metraipolis.com/documento/dc_a198dfb538a2

How to cite

Investigating the Mechanisms of Combined Therapy for MCF-7 Breast Cancer Cells Using Arsenic Trioxide and Resveratrol through Network Pharmacology — Europe PMC PMID:41675270 — Europe PMC (en), https://europepmc.org/article/MED/41675270 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a198dfb538a2 (Metraipolis archive dc_a198dfb538a2, sha256 058cb9b316d392aca8559a0bce39df3afedd81e9ab0a65e2b0be8107f323afc6)
BibTeX
@misc{dca198dfb538a2,
  title = {Investigating the Mechanisms of Combined Therapy for MCF-7 Breast Cancer Cells Using Arsenic Trioxide and Resveratrol through Network Pharmacology — Europe PMC PMID:41675270},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41675270},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a198dfb538a2; sha256 058cb9b316d392aca8559a0bce39df3afedd81e9ab0a65e2b0be8107f323afc6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41675270. Agents can read the archived copy with the MCP tool read_document.